Arcturus Therapeutics Holdings Inc. (ARCT) stock
ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3010% below fair value
$7.97−0.34 (-4.09%)
Close on Nov 17, 2026Market cap $226.53MP/E –Yield –
Arcturus Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Arcturus Therapeutics's market cap was $264.62M on Nov 11, 2026, against $184.93M a year earlier. Over the last 5 years it ranged from $163.72M to $1.05B, with a median of $479.45M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $264.62M | +58.5% |
| 2025 | Dec 31, 2025 | $166.95M | -63.7% |
| 2024 | Dec 31, 2024 | $459.62M | -45.5% |
| 2023 | Dec 29, 2023 | $842.58M | +87.5% |
| 2022 | Dec 30, 2022 | $449.30M | -53.9% |
| 2021 | Dec 31, 2021 | $975.18M | -8.1% |
| 2020 | Dec 31, 2020 | $1.06B | +545.7% |
| 2019 | Dec 31, 2019 | $164.42M | – |
See a number that looks wrong?